IRF8 and chronic myelogenous leukemia, BCR-ABL1 positive: In an early study, low IRF8 expression was detected both in AML and CML patients [16], but more recent genome-wide data suggest that IRF8 is rather highly expressed in AML (Figure 2A,B).